Results 221 to 230 of about 57,018 (256)

Nitrofurantoin polyneuropathy

Neurology, 1973
J F, Toole, M L, Parrish
openaire   +2 more sources

TREATMENT OF POLYNEUROPATHY WITH AZATHIOPRINE

Lancet, The, 1970
L A Liversedge, L A Liversedge
exaly  

Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2011
Haruki Koike, , Yuichi Kawagashira
exaly  

The epidemiology and risk factors of chronic polyneuropathy

European Journal of Epidemiology, 2015
M Arfan Ikram, Rens Hanewinckel, Van Doorn Pieter A   +2 more
exaly  

Amyloid Polyneuropathy

Neurology, 1955
J F, SULLIVAN, T E, TWITCHELL, G J, GHERARDI, W P, VANDERLAAN   +3 more
openaire   +2 more sources

Polyneuropathie

2022
Petra Baum, Wolfgang Böhmerle, Jan Bürmann, Maike F. Dohrn, Kathrin Doppler, Josef Finsterer, Maren Fitzner, Elke Frombach, Christian Geber, Hans-Hilmar Goebel, Nicolai B. Grether, Alexander Grimm, Anna Grisold, Anu Gupta, Petra Hühnchen, Juliane Klehmet, Heike Kölbel, Martin Krenn, Clara Lehmann, Elisabeth Lindeck-Pozza, Georg Mansmann, Stefan Meng, Kalliopi Pitarokoili, Jens Schmidt, Christian Schneider, Peter Schwenkreis, Frauke Stacheit, Werner Stenzel, Fiona Streckmann, Gilbert Wunderlich, Min-Suk Yoon   +30 more
openaire   +1 more source

The Pathogenesis of Organophosphate Polyneuropathy

Critical Reviews in Toxicology, 1992
M Lotti, Marcello Lotti
exaly  

UREMIC POLYNEUROPATHY

Acta Neurologica Scandinavica, 1967
L, Forno, W, Alston
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy

Clinical Neurophysiology, 1999
Antonino Uncini, Alessandra Lugaresi, M V De Angelis   +2 more
exaly  

<p>Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care</p>

Therapeutics and Clinical Risk Management, 2020
Mario Sabatelli, Giulia Bisogni, Marco Luigetti   +2 more
exaly